Stock INM INVENTIONMED S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials InventionMed S.A.

Equities

INM

PLCDE0000010

Advanced Medical Equipment & Technology

End-of-day quote Warsaw S.E.
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
0.239 PLN -0.42% Intraday chart for InventionMed S.A. +5.75% -6.64%
15/05 InventionMed S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/02 InventionMed S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 45.69 44.26 34.73 41.62 27.78 51.91
Enterprise Value (EV) 1 39.89 31.14 34.19 35.97 26.14 55.16
P/E ratio -37.3 x -37 x -76.7 x -61.7 x -1.25 x -27.5 x
Yield - - - - - -
Capitalization / Revenue - 1,07,96,10,195 x 6,67,83,26,923 x 3,98,29,72,536 x 6,83,44,00,984 x 85,80,74,56,198 x
EV / Revenue - 75,94,75,049 x 6,57,57,28,077 x 3,44,24,84,402 x 6,43,05,65,560 x 91,17,19,17,355 x
EV / EBITDA -44.4 x -25.2 x -72.8 x -59.4 x -36.3 x -839 x
EV / FCF -13.5 x -134 x -8.74 x 6.8 x -4.23 x -1.87 x
FCF Yield -7.41% -0.74% -11.4% 14.7% -23.6% -53.5%
Price to Book 3.3 x 3.5 x 1.13 x 1.39 x 3.55 x 8.75 x
Nbr of stocks (in thousands) 1,42,787 1,42,787 2,02,787 2,02,787 2,02,787 2,02,787
Reference price 2 0.3200 0.3100 0.1712 0.2052 0.1370 0.2560
Announcement Date 25/04/19 18/05/21 18/05/21 31/05/22 31/05/23 28/05/24
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - 0.041 0.0052 0.0104 0.004065 0.000605
EBITDA 1 -0.8976 -1.235 -0.4696 -0.6058 -0.7205 -0.0657
EBIT 1 -1.156 -1.303 -0.573 -0.674 -0.7547 -1.165
Operating Margin - -3,177.44% -11,018.33% -6,450.2% -18,565.76% -1,92,602.64%
Earnings before Tax (EBT) 1 -1.224 -1.182 -0.4261 -0.6741 -22.15 -1.889
Net income 1 -1.224 -1.195 -0.4532 -0.6741 -22.15 -1.889
Net margin - -2,914.31% -8,714.79% -6,450.38% -5,45,002.61% -3,12,258.35%
EPS 2 -0.008572 -0.008368 -0.002234 -0.003324 -0.1092 -0.009315
Free Cash Flow 1 -2.955 -0.2319 -3.914 5.287 -6.176 -29.52
FCF margin - -565.55% -75,266.37% 50,597.04% -1,51,929.89% -48,79,734.38%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 25/04/19 18/05/21 18/05/21 31/05/22 31/05/23 28/05/24
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 3.25
Net Cash position 1 5.8 13.1 0.53 5.65 1.64 -
Leverage (Debt/EBITDA) - - - - - -49.39 x
Free Cash Flow 1 -2.95 -0.23 -3.91 5.29 -6.18 -29.5
ROE (net income / shareholders' equity) -9.82% -9.02% -2.09% -2.22% -117% -27.5%
ROA (Net income/ Total Assets) -5.22% -5.96% -1.58% -1.11% -1.27% -1.99%
Assets 1 23.46 20.05 28.75 60.62 1,738 95.05
Book Value Per Share 2 0.1000 0.0900 0.1500 0.1500 0.0400 0.0300
Cash Flow per Share 2 0.0200 0.0200 0 0.0300 0.0200 0
Capex 1 0.01 0.09 3.42 3 8.12 15.3
Capex / Sales - 216.59% 65,750.92% 28,676.53% 1,99,770.48% 25,29,023.14%
Announcement Date 25/04/19 18/05/21 18/05/21 31/05/22 31/05/23 28/05/24
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Software & Technology Services

1st Jan change Capi.
INVENTIONMED S.A. Stock InventionMed S.A.
-6.64% 1.21Cr
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-4.94% 2.99TCr
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+49.49% 969.95Cr
SECTRA AB Stock Sectra AB
+34.36% 442.46Cr
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-42.11% 230.04Cr
VERADIGM INC. Stock Veradigm Inc.
-9.44% 151.95Cr
OMNICELL, INC. Stock Omnicell, Inc.
-28.06% 120.64Cr
LUNIT INC. Stock Lunit Inc.
-42.92% 97Cr
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+8.65% 96Cr
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-47.18% 75Cr
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. INM Stock
  4. Financials InventionMed S.A.